EMILY DAVIS: Open Payments
NPI 1851932727 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,992 in 153 payments from 18 companies in 2025. Trend: 2023 $3,002 · 2024 $2,976 · 2025 $2,992
Food & beverage: $2,992
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $361 |
| ABBVIE INC. | 18 | $330 |
| Neurocrine BioSciences, Inc. | 13 | $323 |
| Alkermes, Inc. | 18 | $265 |
| Lundbeck LLC | 12 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $212 |
| Axsome Therapeutics, Inc. | 13 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $191 |
| Teva Pharmaceuticals USA, Inc. | 9 | $183 |
| Corium, LLC | 6 | $143 |
Products named: REXULTI, INGREZZA, VRAYLAR, CAPLYTA, ARISTADA, TRINTELLIX, AUSTEDO XR, Auvelity.
Industry payments across TX — which companies pay providers there.
